Details of the Probe-central Interaction Altas
General Information of Experiment
Probe Name | C334 | Probe Info | ||||
---|---|---|---|---|---|---|
Probe concentration | Probe:50uM; negative probe:50uM | |||||
Criteria | Quantification: AfBPP Probe vs Negative Probe | |||||
Quantitative Method |
TMT
|
|||||
In Vivo Experiment Model | Model Type |
|
Living cell | |||
Derived Tissue |
|
Peripheral blood | ||||
Disease Model | Normal | |||||
Model Name | Human normal cells (HEK-293T) | |||||
Note | Negative probe:C#CCCC1(CCC(NC)=O)N=N1 |
Interaction Altas of This Experiment [1]
Enzyme
Target ID | Target Name | Binding Ratio | ||||
---|---|---|---|---|---|---|
LDTP16032 | Retinoid-inducible serine carboxypeptidase (SCPEP1) | 8.5 | ||||
LDTP00316 | Ribonuclease T2 (RNASET2) | 8.3 | ||||
LDTP09256 | Putative phospholipase B-like 2 (PLBD2) | 7.8 | ||||
LDTP13358 | Leucyl-cystinyl aminopeptidase (LNPEP) | 7.2 | ||||
LDTP01241 | Bis(monoacylglycero)phosphate synthase CLN5 (CLN5) | 7.1 | ||||
LDTP02141 | Alpha-galactosidase A (GLA) | 7.0 | ||||
LDTP02539 | Lysosomal acid phosphatase (ACP2) | 6.7 | ||||
LDTP08476 | 5'-3' exonuclease PLD3 (PLD3) | 6.1 | ||||
LDTP11215 | Plasma alpha-L-fucosidase (FUCA2) | 5.5 | ||||
LDTP02486 | Lysosomal alpha-glucosidase (GAA) | 5.0 | ||||
LDTP04008 | Endothelin-converting enzyme 1 (ECE1) | 5.0 |
Transporter and channel
Target ID | Target Name | Binding Ratio | ||||
---|---|---|---|---|---|---|
LDTP02071 | Amyloid-beta precursor protein (APP) | 10.1 | ||||
LDTP11615 | Protein tweety homolog 3 (TTYH3) | 6.2 | ||||
LDTP04940 | NPC intracellular cholesterol transporter 2 (NPC2) | 5.8 | ||||
LDTP01969 | Transferrin receptor protein 1 (TFRC) | 5.6 |
Other
Target ID | Target Name | Binding Ratio | ||||
---|---|---|---|---|---|---|
LDTP07703 | Seizure 6-like protein 2 (SEZ6L2) | 15.7 | ||||
LDTP05558 | Galectin-3-binding protein (LGALS3BP) | 8.3 | ||||
LDTP14486 | Clustered mitochondria protein homolog (CLUH) | 5.6 | ||||
LDTP02927 | Ganglioside GM2 activator (GM2A) | 5.0 |